Anal Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-07-03
Clinical Trial Update: VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 [Phase 2]
Phase 2 trial of VGX-3100 delivered intramuscularly with electroporation for HPV-16/18 associated HSIL in HIV-seronegative individuals; stud…